Media Summary: Pathologist Evita Sadimin, MD, reviews current Panelists discuss their neoadjuvant and adjuvant treatment approaches for early-stage HER2+ breast cancer. For more resources ... Tiffany Traina, MD, reviews clinical trials APHINITY and KATHERINE, and how they affect her
Case 1 Guidelines For Her2 - Detailed Analysis & Overview
Pathologist Evita Sadimin, MD, reviews current Panelists discuss their neoadjuvant and adjuvant treatment approaches for early-stage HER2+ breast cancer. For more resources ... Tiffany Traina, MD, reviews clinical trials APHINITY and KATHERINE, and how they affect her Ian Krop, MD, summarizes key clinical trials for neoadjuvant and adjuvant treatments in early-stage HER2+ breast cancer, ... The panel discusses the decision-making process for Denise A. Yardley, MD, considers the diagnostic and prognostic workup of a 56-year-old woman who presents with early-stage ...
Breast cancer experts review adjuvant treatment approaches after failing to achieve a pathologic complete response with ... In this segment, panelists explore the treatment of a 40-year-old woman with a 2 cm mass in her left breast and a 2 cm liver lesion, ...
